CNIO researchers propose a new treatment for brain metastasis based on immunotherapy
CNIO researchers have discovered that cancer perverts certain brain cells, the astrocytes, and causes them to produce a protein that works in favour of the tumour.
A drug, silibinin, inhibits this protein, and could be used to help treat brain metastasis with immunotherapy. A clinical trial is underway.
The work is published in the American Association for Cancer Research's journal Cancer Discovery.
Researchers at the Spanish National Cancer Research Centre (CNIO) propose a new treatment for brain metastases that respond poorly, or not at all, to immunotherapy, and provide a biomarker to predict ...











